15 results
8-K
EX-99.1
IOBT
IO Biotech Inc
13 Nov 23
IO Biotech Announces 2023 Third Quarter Results
8:10am
-clinical data presented demonstrates clear impact of immune modulating vaccines targeting IDO1 and PD-L1 on several tumoral immune escape mechanisms … demonstrate the clear impact of therapeutic vaccines targeting IDO1 and PD-L1 on several tumoral immune escape mechanisms in the tumor microenvironment
10-K
u07i5 vcyppakbxjj2v
31 Mar 22
Annual report
5:07pm
424B4
wxy9st0fz hdap1zz
8 Nov 21
Prospectus supplement with pricing info
5:20pm
S-1
7zm7 cifptqz2zc
15 Oct 21
IPO registration
5:18pm
DRS/A
5t7cnvo
6 Oct 21
Draft registration statement (amended)
12:00am
DRS/A
oisew t68ef
9 Aug 21
Draft registration statement (amended)
12:00am
DRS
eevgj gethpbsig
3 Jun 21
Draft registration statement
12:00am
- Prev
- 1
- Next